'Real world' pain outcomes and experiences of care for patients with musculoskeletal conditions in general practice (the MIDAS-GP study)

'Real world' pain outcomes and experiences of care (MIDAS-GP)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN18132064

Enrollment

1424

Registered

2021-06-25

Start date

2021-09-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common musculoskeletal conditions that involve pain Musculoskeletal Diseases Diseases of the musculoskeletal system and connective tissue, painful non-inflammatory musculoskeletal disorders

Interventions

Adults consulting their general practice with a painful musculoskeletal condition will be invited to answer some questions about their condition and their care either through an online questionnaire (

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged =18 years 2. Registered with a participating general practice during the study period 3. Consulting any primary healthcare professional in the general practice for painful, non-inflammatory musculoskeletal disorder during the study period (according to predefined SNOMED code lists) 4. Able to read/understand English with or without assistance (patient-report survey component only) 5. Able to provide informed consent (patient-report survey component only)

Exclusion criteria

Exclusion criteria: 1. Inflammatory musculoskeletal disease (according to predefined SNOMED code lists retrospectively examined over the previous 3 years) 2. Has indicated in the record that they do not consent to be approached about research studies

Design outcomes

Primary

Measure	Time frame
1. Pain intensity measured using a 0-10 Number Rating Scale (NRS) at baseline, 1, 2, 3, 4, 5 and 6 months 2. Musculoskeletal pain measured using a Musculoskeletal Health Questionnaire (MSK-HQ) at baseline, 3, and 6 months	—

Secondary

Measure	Time frame
1. Pain Intensity measured using the Pain Intensity and Interference PEG (Pain, Enjoyment, General Activity) scale at baseline, 3, and 6 months 2. High impact chronic pain measured using a questionnaire at baseline, 3, and 6 months 3. Work status, absenteeism, and productivity loss measured using a questionnaire at baseline, 3, and 6 months 4. Global perceived change measured using a questionnaire at baseline, 3, and 6 months 5. Patient experience measured using a questionnaire at baseline 6. Healthcare use measured using a questionnaire at baseline, 3, and 6 months	—

Measure

Time frame

1. Pain Intensity measured using the Pain Intensity and Interference PEG (Pain, Enjoyment, General Activity) scale at baseline, 3, and 6 months 2. High impact chronic pain measured using a questionnaire at baseline, 3, and 6 months 3. Work status, absenteeism, and productivity loss measured using a questionnaire at baseline, 3, and 6 months 4. Global perceived change measured using a questionnaire at baseline, 3, and 6 months 5. Patient experience measured using a questionnaire at baseline 6. Healthcare use measured using a questionnaire at baseline, 3, and 6 months

—

Countries

England, United Kingdom

Contacts

Public ContactJonathan;Clare Hill;Thompson

;

j.hill@keele.ac.uk;c.thompson1@keele.ac.uk+44 (0)1782 733900;+44 (0)1782 732950

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026